Navigation Links
VGXI Celebrates Grand Opening of New Flex-Scale Production Plant for GMP RNA and DNA Therapeutics Manufacturing
Date:11/7/2018

VGXI, an industry recognized plasmid DNA contract manufacturing organization, announced the grand opening of a facility expansion which includes flexible scale plasmid DNA manufacturing space as well as purpose-built GMP production areas for RNA synthesis.

Increasing the company’s footprint by 17% and cGMP manufacturing space by over 70%, this expansion was initiated in anticipation of the recently finalized license and partnership with Houston Methodist Research Institute (HMRI). Under the partnership, technology transfer for clinical grade RNA manufacturing capabilities is already underway from HMRI, providing an ideal complement to VGXI’s existing DNA production services.

The ribbon cutting ceremony held Friday, November 2nd 2018 was attended by U.S. Congressman Kevin Brady as well representatives of the Texas biotechnology community, including BioHouston CEO, Ann Tanabe. During the ceremony Congressman Brady presented VGXI’s President and CEO Young Park with a Commendation on behalf of the U.S. House of Representatives for the company’s continued contributions to the biotechnology industry and local community.

In response to the growing success and worldwide demand for gene based medicines, VGXI has continued to improve and broaden their services with three facility expansions in just the past 4 years. According to CEO Mr. Park, “The current expansion is just one part of the company’s overall plan to keep pace with industry. We are already evaluating locations for VGXI’s next phase facility for commercial DNA and RNA production.”

ABOUT VGXI
VGXI, Inc. has over 15 years of experience and is a leading provider of manufacturing and development services for DNA vaccines and gene therapies. The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. VGXI, Inc. is a wholly-owned subsidiary CMO of GeneOne Life Science, Inc. To learn more or request a quote, visit http://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE
GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) is an international DNA vaccine and product developer and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne's wholly-owned manufacturing subsidiary located in Texas, is the largest pure-play cGMP DNA plasmid manufacturing facility in the world. For more information, visit http://www.genels.com/en.

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS
Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

Read the full story at https://www.prweb.com/releases/vgxi_celebrates_grand_opening_of_new_flex_scale_production_plant_for_gmp_rna_and_dna_therapeutics_manufacturing/prweb15895451.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. NACDD Celebrates 30th Anniversary with Launch of New Website
2. Dreamfields Pasta Celebrates the Love of Pasta During #HealthyPastaMonth2018
3. Cold War Patriots Celebrates 10th Annual Official National Day of Remembrance™
4. Lefty’s the Left Hand Store Celebrates International Left Handers Day on Monday, August 13, with Fun, Games and Gifts
5. ThriveRx Celebrates 10th Anniversary, Launches New Platforms
6. Phoenix Marketing Solutions Celebrates 15th Anniversary!
7. Cold Chain Technologies Celebrates 50th Anniversary and New Headquarters
8. The Leukemia & Lymphoma Societys 2017 Leukemia Ball, Presented by PhRMA, Celebrates 30th Anniversary with Record-Breaking $4.1 Million Raised for Cancer Cures
9. ISCDD Celebrates 15th Anniversary of Improving CNS Drug Development Through Collaboration Amongst Stakeholders
10. International Biophysics Announces 34% Revenue Growth for 2016 as it Celebrates 25 Years in the Medical Device Industry.
11. MDA Celebrates News of FDA Approval of Emflaza for Treatment of Duchenne Muscular Dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... January 24, 2020 , ... Each year Therapy and Beyond, ... organizations to host Mom’s Mingles that are designed for 100+ moms of children with ... same journey, and ultimately, enjoy a night of carefree fun. The highly anticipated 3rd ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... The California ... Sunlit Gardens, a Meridian Senior Living assisted living and memory care ... of quality and distinction in our resident care that 100% deficiency-free status reflects,” expressed ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... trusted Australian Dream® for effective relief. Now, the company is unveiling ... Australian Dream sought to develop a new design that better communicates the quality ...
Breaking Medicine Technology:
(Date:1/23/2020)... ... 2020 , ... The American Heart Association (AHA), the leading voluntary health organization ... County Go Red for Women Luncheon will take place Friday, February 21, 2020, ... residents are anticipated to attend the premier event designed to raise awareness and funds ...
(Date:1/23/2020)... ... ... Worldwide Business with kathy ireland® is pleased to announce an exclusive ... Dairy and Frozen, Jimmy Farber to discuss their healthy, affordable all organic food and ... options at an affordable price. The company believes that the best foods are the ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... Let’s face ... dynamics came out strongly. Old family issues, rivalries, and secrets were revisited. It’s easy ... many of those coping with addiction and their families, the holidays posed additional stress ...
(Date:1/23/2020)... ... January 23, 2020 , ... Three leading ... take action to improve diagnostic quality and safety by joining the Coalition ... organizations in healthcare and patient advocacy. , “Diagnostic error is one of the ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... programs and services that improve workforce resilience, is presenting at the NATSAP 2020 ... an advocate and resource for organizations that devote themselves to society’s need for ...
Breaking Medicine News(10 mins):